News and Trends 5 Dec 2022First subject dosed in inflammation phase I study Innovent Biologics, Inc. and UNION therapeutics A/S have announced that the first Chinese healthy volunteer has been successfully dosed in… December 5, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email